337 related articles for article (PubMed ID: 33040225)
1. Obesity Genomics and Metabolomics: a Nexus of Cardiometabolic Risk.
Regan JA; Shah SH
Curr Cardiol Rep; 2020 Oct; 22(12):174. PubMed ID: 33040225
[TBL] [Abstract][Full Text] [Related]
2. Branched chain amino acids: Passive biomarkers or the key to the pathogenesis of cardiometabolic diseases?
Siomkajło M; Daroszewski J
Adv Clin Exp Med; 2019 Sep; 28(9):1263-1269. PubMed ID: 31430068
[TBL] [Abstract][Full Text] [Related]
3. Alterations of plasma metabolite profiles related to adipose tissue distribution and cardiometabolic risk.
Boulet MM; Chevrier G; Grenier-Larouche T; Pelletier M; Nadeau M; Scarpa J; Prehn C; Marette A; Adamski J; Tchernof A
Am J Physiol Endocrinol Metab; 2015 Oct; 309(8):E736-46. PubMed ID: 26306599
[TBL] [Abstract][Full Text] [Related]
4. Integrated metabolomics and genomics: systems approaches to biomarkers and mechanisms of cardiovascular disease.
Shah SH; Newgard CB
Circ Cardiovasc Genet; 2015 Apr; 8(2):410-9. PubMed ID: 25901039
[TBL] [Abstract][Full Text] [Related]
5. Diabetes and branched-chain amino acids: What is the link?
Bloomgarden Z
J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
[TBL] [Abstract][Full Text] [Related]
6. Linking of metabolomic biomarkers with cardiometabolic health in Chinese population.
Sun L; Li H; Lin X
J Diabetes; 2019 Apr; 11(4):280-291. PubMed ID: 30239137
[TBL] [Abstract][Full Text] [Related]
7. The relationship between BMI and metabolomic profiles: a focus on amino acids.
Morris C; O'Grada C; Ryan M; Roche HM; Gibney MJ; Gibney ER; Brennan L
Proc Nutr Soc; 2012 Nov; 71(4):634-8. PubMed ID: 22863201
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic biomarkers for obesity in humans: a short review.
Rauschert S; Uhl O; Koletzko B; Hellmuth C
Ann Nutr Metab; 2014; 64(3-4):314-24. PubMed ID: 25300275
[TBL] [Abstract][Full Text] [Related]
9. Omics and Cardiometabolic Disease Risk Prediction.
Tahir UA; Gerszten RE
Annu Rev Med; 2020 Jan; 71():163-175. PubMed ID: 31986080
[TBL] [Abstract][Full Text] [Related]
10. Dietary branched-chain amino acid restriction alters fuel selection and reduces triglyceride stores in hearts of Zucker fatty rats.
McGarrah RW; Zhang GF; Christopher BA; Deleye Y; Walejko JM; Page S; Ilkayeva O; White PJ; Newgard CB
Am J Physiol Endocrinol Metab; 2020 Feb; 318(2):E216-E223. PubMed ID: 31794262
[TBL] [Abstract][Full Text] [Related]
11. Associations between branched chain amino acid intake and biomarkers of adiposity and cardiometabolic health independent of genetic factors: A twin study.
Jennings A; MacGregor A; Pallister T; Spector T; Cassidy A
Int J Cardiol; 2016 Nov; 223():992-998. PubMed ID: 27591698
[TBL] [Abstract][Full Text] [Related]
12. Identification of serum metabolites associated with obesity and traditional risk factors for metabolic disease in Chinese adults.
Wang SM; Yang RY; Wang M; Ji FS; Li HX; Tang YM; Chen WX; Dong J
Nutr Metab Cardiovasc Dis; 2018 Feb; 28(2):112-118. PubMed ID: 29122443
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics in diabetes, a review.
Pallares-Méndez R; Aguilar-Salinas CA; Cruz-Bautista I; Del Bosque-Plata L
Ann Med; 2016; 48(1-2):89-102. PubMed ID: 26883715
[TBL] [Abstract][Full Text] [Related]
14. Early Programming of Obesity Throughout the Life Course: A Metabolomics Perspective.
Rauschert S; Kirchberg FF; Marchioro L; Koletzko B; Hellmuth C; Uhl O
Ann Nutr Metab; 2017; 70(3):201-209. PubMed ID: 28301839
[TBL] [Abstract][Full Text] [Related]
15. Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome.
Chang AY; Lalia AZ; Jenkins GD; Dutta T; Carter RE; Singh RJ; Nair KS
Metabolism; 2017 Jun; 71():52-63. PubMed ID: 28521878
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers for the prediction of type 2 diabetes and cardiovascular disease.
Herder C; Karakas M; Koenig W
Clin Pharmacol Ther; 2011 Jul; 90(1):52-66. PubMed ID: 21654741
[TBL] [Abstract][Full Text] [Related]
17. Genomic and Metabolomic Profile Associated to Clustering of Cardio-Metabolic Risk Factors.
Marrachelli VG; Rentero P; Mansego ML; Morales JM; Galan I; Pardo-Tendero M; Martinez F; Martin-Escudero JC; Briongos L; Chaves FJ; Redon J; Monleon D
PLoS One; 2016; 11(9):e0160656. PubMed ID: 27589269
[TBL] [Abstract][Full Text] [Related]
18. Branched Chain Amino Acids, Cardiometabolic Risk Factors and Outcomes in Older Men: The Concord Health and Ageing in Men Project.
Le Couteur DG; Ribeiro R; Senior A; Hsu B; Hirani V; Blyth FM; Waite LM; Simpson SJ; Naganathan V; Cumming RG; Handelsman DJ
J Gerontol A Biol Sci Med Sci; 2020 Sep; 75(10):1805-1810. PubMed ID: 31428789
[TBL] [Abstract][Full Text] [Related]
19. Metabolic switch during adipogenesis: From branched chain amino acid catabolism to lipid synthesis.
Halama A; Horsch M; Kastenmüller G; Möller G; Kumar P; Prehn C; Laumen H; Hauner H; Hrabĕ de Angelis M; Beckers J; Suhre K; Adamski J
Arch Biochem Biophys; 2016 Jan; 589():93-107. PubMed ID: 26408941
[TBL] [Abstract][Full Text] [Related]
20. Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine.
Ogino S; Nishihara R; VanderWeele TJ; Wang M; Nishi A; Lochhead P; Qian ZR; Zhang X; Wu K; Nan H; Yoshida K; Milner DA; Chan AT; Field AE; Camargo CA; Williams MA; Giovannucci EL
Epidemiology; 2016 Jul; 27(4):602-11. PubMed ID: 26928707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
